May 29, 2020
Amy DuRoss selected for San Francisco Business Times’ Most Influential Women of 2020
Today, we’re proud to congratulate our CEO and Co-founder, Amy DuRoss, for her selection to the prestigious San Francisco Business Times’ “Most Influential Women in Bay Area Business” awards list.
The honor recognizes outstanding women leaders who make a difference in their companies, industries, and communities. Amy is profiled in a special, printed supplement to the SFBT’s issue today. She will also be honored at an awards ceremony in October.
This year, this recognition takes on new meaning. As the SFBT noted in announcing this award, “the Covid-19 pandemic is changing how business is done.” Amy is no stranger to leading healthcare-related organizations through change. She has guided several other start-up ventures in the past, and served as co-founder and Executive Director of Proposition 71, California’s $3B stem cell research initiative passed in 2004.
“The COVID-19 pandemic has certainly introduced some new pressures, but also many new opportunities,” Amy said. “We must all come together to solve this challenge and keep other parts of the healthcare ecosystem moving forward at the same time, including the advanced therapies that Vineti serves. I’m very humbled by this award, and I plan to keep doing all I can to help provide solutions and save lives.”
Here are five of the ways Amy has kept Vineti moving ahead in 2020:
- In March, our new Chief Technology Officer, Phil Calvin, joined the company. Phil is a veteran of Salesforce, other SaaS innovation companies, and his own start-ups.
- Vineti made plans early in the pandemic to keep operations moving safely and smoothly amid COVID-19.
- Two other new executives joined us this year — Chief Strategy Officer Louise Pacini and Chief Financial Officer Brett Robertson. Both are accomplished healthcare and tech leaders (and both happen to be women).
- Vineti announced a new collaboration with Fortune 20 leader Cardinal Health to support cell and gene therapy manufacturers.
- Vineti turned four years old this spring, and found new ways to celebrate together, even while working apart!
There’s a lot of other good news coming in the months ahead, both from the world of advanced therapies and from Vineti. We look forward to sharing more soon. If you’ve got some news of your own, please let us know.
If we can help you with your advanced therapy questions in this uncertain time, please contact us. You may also want to take a look at our Cell and Gene Therapies COVID-19 Briefing.